Product Information

TOPIRAMATE ER 100 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $7.3379 per EA under NDC 10370036701. Its NADAC has been published 177 times since Jul 5, 2023.

FDA first approved this application on Mar 1, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 100 MG CAPSULE

Topiramate
$7.3379per EA

Strength

100 mg/1

Manufacturer

Endo USA Inc.

NDC

10370036701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA205976

FDA Approved

3/1/2023

TE Code

AB1

On Market Since

5/24/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 100 MG CAPSULE has been published 177 times since Jul 5, 2023, and over the history we have for it it has declined 71.1%. The table below summarizes its recorded NADAC range and movement.

Current price$7.3379 per EA
All-time high$25.3872 (Jul 12, 2023)
All-time low$7.3379 (Nov 18, 2026)
52-week high$13.4017
52-week low$7.3379
Median price$13.4348
Average price$14.4560
Largest weekly change+38.3% (Aug 21, 2024)
Weeks tracked177
Tracking sinceJul 5, 2023

Price History

1W

-19.4%

1M

-31.3%

3M

-28.1%

6M

-36.7%

1Y

-45.2%

3Y

-60.5%

5Y

N/A

All

-71.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG CAPSULE, manufactured by Endo USA Inc., is $7.3379 per EA (NDC 10370036701), effective Nov 18, 2026.

How has the price of TOPIRAMATE ER 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has declined 71.1%. It has been tracked across 177 weekly CMS publications since Jul 5, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG CAPSULE?

Since Jul 5, 2023, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has ranged from a low of $7.3379 (Nov 18, 2026) to a high of $25.3872 (Jul 12, 2023), with a median of $13.4348 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 100 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 100 MG SPRINK CAP, is $6.0614 per EA — about 17% below TOPIRAMATE ER 100 MG CAPSULE.

Who manufactures TOPIRAMATE ER 100 MG CAPSULE?

TOPIRAMATE ER 100 MG CAPSULE (NDC 10370036701) is labeled by Endo USA Inc., and CMS classifies it as a generic product.